Spain· ES:06366018
TANDEMACT 30 mg/2 mg COMPRIMIDOS
A medicinal product containing glimepirida + pioglitazona, registered in Spain by Cheplapharm Arzneimittel Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- glimepirida + pioglitazona
- Manufacturer
- Cheplapharm Arzneimittel Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo66316228EUR 56.46
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glimepirida + pioglitazona in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDuetactTakeda Pharmaceuticals America, Inc.
- FinlandTandemactCheplapharm Arzneimittel GmbH
- IcelandTandemactCHEPLAPHARM Arzneimittel GmbH
- NetherlandsTandemact 30 mg/2 mg, tablettenCHEPLAPHARM Arzneimittel GmbH
- PolandTandemactCHEPLAPHARM Arzneimittel GmbH
- SwedenTandemact 30 mg/2 mg TablettCheplapharm Arzneimittel GmbH
- IrelandTandemactCHEPLAPHARM Arzneimittel GmbH
- CzechiaTANDEMACTCHEPLAPHARM Arzneimittel GmbH, Greifswald
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tandemact
- Liechtenstein · Tandemact
- Norway · Tandemact
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d88ed6d5-38b0-49d5-a651-bd6f72186f5b GET /v1/drugs/d88ed6d5-38b0-49d5-a651-bd6f72186f5b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1254175200000}",
"nregistro": "06366018",
"substance": "glimepirida + pioglitazona"
}See everything about glimepirida + pioglitazona.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.